Journal of Peking University(Health Sciences) >
Effect of Porphyromonas gingivalis infection on atherosclerosis in apolipoprotein-E knockout mice
Received date: 2018-10-11
Online published: 2020-08-06
Supported by
National Natural Science Foundation of China(81271148);National Natural Science Foundation of China(8140030482)
Objective: Studies have indicated that periodontal pathogen Porphyromonas gingivalis (P. gingivalis) infection may contributed to accelerate the development of atherosclerosis. The aim of this study was to investigate the effect of inflammation, oxidative stress and the mechanism on atherosclerosis in apolipoprotein-E knockout (ApoE-/-) mice with P. gingivalis infection. Methods: Eight-week-old male ApoE-/- mice (C57BL/6) were maintained under specific pathogen-free conditions and fed regular chow and sterile water after 1 weeks of housing. The animals were randomly divided into two groups: (a) ApoE-/- + PBS (n=8); (b) ApoE-/- + P.gingivalis strain FDC381 (n=8). Both of the groups received intravenous injections 3 times per week for 4 weeks since 8 weeks of age. The sham control group received injections with phosphate buffered saline only, while the P. gingivalis-challenged group with P.gingivalis strain FDC381at the same time. After 4 weeks, oxidative stress mediators and inflammation cytokines were analyzed by oil red O in heart, Enzyme linked immunosorbent assay (ELISA) in serum, quantitative real-time PCR and Western blot in aorta. Results: In our study, we found accelerated development of atherosclerosis and plaque formation in aorta with oil red O staining, increased oxidative stress markers [8-hydroxy-2-deoxyguanosine (8-OHdG), NADPH oxidase (NOX)-2 and NOX-4], as well as increased inflammation cytokines [interleukin (IL)-1β, IL-6 and tumor necrosis factor-α (TNF-α)] in the serum and aorta of the P. gingivalis-infected ApoE-/- mice. Compared with the control group, there was a significant increase protein level of nuclear factor-kappa B (NF-κB) in aorta after P. gingivalis infection. Conclusion: Our results suggest that chronic intravenous infection of P. gingivalis in ApoE-/- mice could accelerate the development of atherosclerosis by disturbing the lipid profile and inducing oxidative stress and inflammation. The NF-κB signaling pathway might play a potential role in the P. gingivalis-accelerated atherogenesis.
Yan XUAN , Yu CAI , Xiao-xuan WANG , Qiao SHI , Li-xin QIU , Qing-xian LUAN . Effect of Porphyromonas gingivalis infection on atherosclerosis in apolipoprotein-E knockout mice[J]. Journal of Peking University(Health Sciences), 2020 , 52(4) : 743 -749 . DOI: 10.19723/j.issn.1671-167X.2020.04.028
| [1] | Cutler CW, Kalmar JR, Genco CA. Pathogenic strategies of the oral anaerobe, Porphyromonas gingivalis[J]. Trends Microbiol, 1995,3(2):45-51. |
| [2] | Holt SC, Kesavalu L, Walker S, et al. Virulence factors of Porphyromonas gingivalis[J]. Periodontol 2000,1999(20):168-238. |
| [3] | DeStefano F, Anda RF, Kahn HS, et al. Dental disease and risk of coronary heart disease and mortality[J]. BMJ, 1993,306(6879):688-691. |
| [4] | Southerland JH, Taylor GW, Moss K, et al. Commonality in chronic inflammatory diseases: Periodontitis, diabetes, and coronary artery disease[J]. Periodontol 2000, 2006,40(1):130-143. |
| [5] | Dogan B, Buduneli E, Emingil G, et al. Characteristics of periodontal microflora in acute myocardial infarction[J]. J Periodontol, 2005,76(5):740-748. |
| [6] | Jain A, Batista EL Jr, Serhan C, et al. Role for periodontitis in the progression of lipid deposition in an animal model[J]. Infect Immun, 2003,71(10):6012-6018. |
| [7] | Ishihara K, Nabuchi A, Ito R, et al. Correlation between detection rates of periodontopathic bacterial DNA in carotid coronary stenotic artery plaque and in dental plaque samples[J]. J Clin Microbiol, 2004,42(3):1313-1315. |
| [8] | Nakano K, Inaba H, Nomura R, et al. Distribution of Porphyromonas gingivalis fimA genotypes in cardiovascular specimens from Japanese patients[J]. Oral Microbiol Immunol, 2008,23(2):170-172. |
| [9] | Kozarov EV, Dorn BR, Shelburne CE, et al. Human atherosclerotic plaque contains viable invasive Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis[J]. Arterioscler Thromb Vasc Biol, 2005,25(3):e17-e18. |
| [10] | Fukasawa A, Kurita-Ochiai T, Hashizume T, et al. Porphyromonas gingivalis accelerates atherosclerosis in C57BL/6 mice fed a high-fat diet[J]. Immunopharmacol Immunotoxicol, 2012,34(3):470-476. |
| [11] | Yu H, Qi LT, Liu LS, et al. Association of carotid intima-media thickness and atherosclerotic plaque with periodontal status[J]. J Dent Res, 2014,93(8):744-751. |
| [12] | Lin G, Chen S, Lei L, et al. Effects of intravenous injection of Porphyromonas gingivalis on rabbit inflammatory immune response and atherosclerosis [J/OL]. Mediators Inflamm, 2015: 364391. doi: 10.1155/2015/364391. |
| [13] | Paigen B, Morrow A, Holmes PA, et al. Quantitative assessment of atherosclerotic lesions in mice[J]. Atherosclerosis, 1987,68(3):231-240. |
| [14] | Bélanger M, Rodrigues PH, Dunn WA, et al. Autophagy: A highway for Porphyromonas gingivalis in endothelial cells[J]. Autophagy, 2006,2(3):165-170. |
| [15] | Iwai T. Periodontal bacteremia and various vascular diseases[J]. J Periodontal Res, 2009,44(6):689-694. |
| [16] | Campbell LA, Rosenfeld ME. Infection and atherosclerosis deve-lopment[J]. Arch Med Res, 2015,46(5):339-350. |
| [17] | Mattila KJ, Nieminen MS, Valtonen VV, et al. Association between dental health and acute myocardial infarction[J]. BMJ, 1989,298(6676):779-781. |
| [18] | Chiu B. Multiple infections in carotid atherosclerotic plaques[J]. Am Heart J, 1999,138(5 Pt 2):S534-S536. |
| [19] | Haraszthy VI, Zambon JJ, Trevisan M, et al. Identification of periodontal pathogens in atheromatous plaques[J]. J Periodontol, 2000,71(10):1554-1560. |
| [20] | Nakano K, Miyamoto E, Tamura K, et al. Distribution of 10 periodontal bacterial species in children and adolescents over a 7-year period[J]. Oral Dis, 2008,14(7):658-664. |
| [21] | Wada K, Kamisaki Y. Roles of oral bacteria in cardiovascular diseases. From molecular mechanisms to clinical cases: Involvement of Porphyromonas gingivalis in the development of human aortic aneurysm[J]. J Pharmacol Sci, 2010,113(2):115-119. |
| [22] | Miyakawa H, Honma K, Qi M, et al. Interaction of Porphyromonas gingivalis with low-density lipoproteins: implications for a role for periodontitis in atherosclerosis[J]. J Periodontal Res, 2004,39(1):1-9. |
| [23] | Li XY, Wang C, Xiang XR, et al. Porphyromonas gingivalis lipopolysaccharide increases lipid accumulation by affecting CD36 and ATP-binding cassette transporter A1 in macrophages[J]. Oncol Rep, 2013,30(3):1329-1336. |
| [24] | Qi M, Miyakawa H, Kuramitsu HK. Porphyromonas gingivalis induces murine macrophage foam cell formation[J]. Microb Pathog, 2003,35(6):259-267. |
| [25] | Ross R. Atherosclerosis is an inflammatory disease[J]. Am Heart J, 1999,138(5 Pt 2):S419-S420. |
| [26] | Hansson GK. Inflammation and immune response in atherosclerosis[J]. Curr Atheroscler Rep, 1999,1(2):150-155. |
| [27] | Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis[J]. Nature, 2011,473(7347):317-325. |
| [28] | Ramji DP, Davies TS. Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets[J]. Cytokine Growth Factor Rev, 2015,26(6):673-685. |
| [29] | Rosenson RS, Elliott M, Stasiv Y, et al. Randomized trial of an inhibitor of secretory phospholipase A2 on atherogenic lipoprotein subclasses in statin-treated patients with coronary heart disease[J]. Eur Heart J, 2011,32(8):999-1005. |
| [30] | Hayashi C, Papadopoulos G, Gudino CV, et al. Protective role for TLR4 signaling in atherosclerosis progression as revealed by infection with a common oral pathogen[J]. J Immunol, 2012,189(7):3681-3688. |
| [31] | Gibson FC 3rd, Ukai T, Genco CA. Engagement of specific innate immune signaling pathways during Porphyromonas gingivalis induced chronic inflammation and atherosclerosis[J]. Front Biosci, 2008(13):2041-2059. |
| [32] | Pan S, Lei L, Chen S, et al. Rosiglitazone impedes Porphyromonas gingivalis-accelerated atherosclerosis by downregulating the TLR/NF-κB signaling pathway in atherosclerotic mice[J]. Int Immunopharmacol, 2014,23(2):701-708. |
| [33] | Huang CY, Shih CM, Tsao NW, et al. The GroEL protein of Porphyromonas gingivalis regulates atherogenic phenomena in endothelial cells mediated by up-regulating toll-like receptor 4 expression[J]. Am J Transl Res, 2016,8(2):384-404. |
| [34] | Khlgatian M, Nassar H, Chou HH, et al. Fimbria-dependent activation of cell adhesion molecule expression in Porphyromonas gingivalis-infected endothelial cells[J]. Infect Immun, 2002,70(1):257-267. |
| [35] | Gitlin JM, Loftin CD. Cyclooxygenase-2 inhibition increases lipopolysaccharide-induced atherosclerosis in mice[J]. Cardiovasc Res, 2009,81(2):400-407. |
| [36] | Huang KT, Kuo L, Liao JC. Lipopolysaccharide activates endothelial nitric oxide synthase through protein tyrosine kinase[J]. Biochem Biophys Res Commun, 1998,245(1):33-37. |
| [37] | Obermeier F, Gross V, Scholmerich J, et al. Interleukin-1 production by mouse macrophages is regulated in a feedback fashion by nitric oxide[J]. J Leukoc Biol, 1999,66(5):829-836. |
| [38] | Sorescu D, Weiss D, Lassègue B. Superoxide production and expression of nox family proteins in human atherosclerosis[J]. Circulation, 2002,105(12):1429-1435. |
| [39] | Sz?cs K, Lassègue B, Sorescu D, et al. Upregulation of Nox-based NAD(P)H oxidases in restenosis after carotid injury[J]. Arterioscler Thromb Vasc Biol, 2002,22(1):21-27. |
| [40] | Anrather J, Racchumi G, Iadecola C. NF-kappaB regulates pha-gocytic NADPH oxidase by inducing the expression of gp91phox[J]. J Biol Chem, 2006,281(9):5657-5667. |
| [41] | Morris KR, Lutz RD, Choi HS, et al. Role of the NF-kappaB signaling pathway and kappaB cis-regulatory elements on the IRF-1 and iNOS promoter regions in mycobacterial lipoarabinomannan induction of nitric oxide[J]. Infect Immun, 2003,71(3):1442-1452. |
| [42] | Deng WG, Zhu Y, Wu KK. Up-regulation of p300 binding and p50 acetylation in tumor necrosis factor-alpha-induced cyclooxygenase-2 promoter activation[J]. J Biol Chem, 2003,278(7):4770-4777. |
| [43] | Brown K, Gerstberger S, Carlson L, et al. Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation[J]. Science, 1995,267(5203):1485-1488. |
| [44] | Luoma JS, Stralin P, Marklund SL, et al. Expression of extracellular SOD and iNOS in macrophages and smooth muscle cells in human and rabbit atherosclerotic lesions: colocalization with epitopes characteristic of oxidized LDL and peroxynitrite-modified proteins[J]. Arterioscler Thromb Vasc Biol, 1998,18(2):157-167. |
| [45] | Morgan MJ, Liu ZG. Crosstalk of reactive oxygen species and NF-kappa B signaling[J]. Cell Res, 2011,21(1):103-115. |
| [46] | Stocker R, Keaney JF Jr. Role of oxidative modifications in atherosclerosis[J]. Physiol Rev, 2004,84(4):1381-1478. |
/
| 〈 |
|
〉 |